JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 18, 2008; DOI: 10.1124/jpet.108.140335


0022-3565/08/3273-634-644$20.00
JPET 327:634-644, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.108.140335v1
327/3/634    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, X.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, X.
Right arrow Articles by Roth, R. A.

TOXICOLOGY

Gene Expression Profiles in Livers from Diclofenac-Treated Rats Reveal Intestinal Bacteria-Dependent and -Independent Pathways Associated with Liver InjuryFormula

Xiaomin Deng, Michael J. Liguori, Erica M. Sparkenbaugh, Jeffrey F. Waring, Eric A. G. Blomme, Patricia E. Ganey, and Robert A. Roth

Departments of Biochemistry and Molecular Biology (X.D.) and Pharmacology and Toxicology (E.M.S., P.E.G., R.A.R.), Michigan State University, East Lansing, Michigan; and Department of Cellular and Molecular Toxicology, Abbott Laboratories, Abbott Park, Illinois (M.J.L., J.F.W., E.A.G.B.)

Diclofenac (DCLF) is a nonsteroidal anti-inflammatory drug that is associated with idiosyncratic adverse drug reactions in humans. Previous studies revealed a crucial role for intestine-derived bacteria and/or lipopolysaccharide (LPS) in DCLF-induced hepatotoxicity. We further explored this mechanism by conducting gene expression analysis of livers from rats treated with a hepatotoxic dose of DCLF (100 mg/kg) with or without oral antibiotic pretreatment. Genes for which expression was altered by DCLF were divided into two groups: genes with expression altered by antibiotic treatment and those unaffected by antibiotics. The former group of genes represented the ones for which DCLF-induced alterations in expression depended on intestinal bacteria. The expression of the latter group of genes was probably changed by direct effect of DCLF rather than by intestinal bacteria. Functional analysis of genes in the former group revealed LPS-related signaling, further suggesting a role for bacterial endotoxin in the liver injury. Functional analysis of genes in the latter group revealed changes in signaling pathways related to inflammation, hypoxia, oxidative stress, the aryl hydrocarbon receptor, and peroxisome proliferator-activated receptor {alpha}. Neutrophil depletion failed to protect from DCLF-induced hepatotoxicity, suggesting that intestinal bacteria contribute to liver injury in a neutrophil-independent manner. Hypoxia occurred in the livers of rats treated with DCLF, and hypoxia in vitro rendered hepatocytes sensitive to DCLF-induced cytotoxicity. These results support the hypothesis that intestinal bacteria are required for DCLF-induced hepatotoxicity and suggest that hypoxia plays an important role in the pathogenesis.


Received for publication April 24, 2008
Accepted September 9, 2008.

Address correspondence to: Robert A. Roth, Department of Pharmacology and Toxicology, B347, Life Sciences Building, Michigan State University, East Lansing, MI 48824. E-mail: rothr{at}msu.edu




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
X. Deng, J. P. Luyendyk, P. E. Ganey, and R. A. Roth
Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models
Pharmacol. Rev., September 1, 2009; 61(3): 262 - 282.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.